• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.p53凋亡刺激蛋白(ASPP2)杂合小鼠易患肿瘤,且细胞损伤反应阈值降低。
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4390-5. doi: 10.1073/pnas.0809080106. Epub 2009 Feb 26.
2
ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.ASPP2是一种单倍体不足的肿瘤抑制因子,它与p53协同作用以抑制肿瘤生长。
Genes Dev. 2006 May 15;20(10):1262-7. doi: 10.1101/gad.374006.
3
New insights into the expanding complexity of the tumor suppressor ASPP2.对肿瘤抑制因子ASPP2不断扩展的复杂性的新见解。
Cell Cycle. 2009 Sep 15;8(18):2871-6. doi: 10.4161/cc.8.18.9474. Epub 2009 Sep 8.
4
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.p53-2凋亡刺激蛋白(ASPP2/53BP2L)是一种E2F靶基因。
Cell Death Differ. 2005 Apr;12(4):358-68. doi: 10.1038/sj.cdd.4401536.
5
Control of ASPP2/(53BP2L) protein levels by proteasomal degradation modulates p53 apoptotic function.蛋白酶体降解对ASPP2/(53BP2L)蛋白水平的调控可调节p53的凋亡功能。
J Biol Chem. 2005 Oct 14;280(41):34473-80. doi: 10.1074/jbc.M503736200. Epub 2005 Aug 9.
6
ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.ΔN-ASPP2是肿瘤抑制因子ASPP2的一种新型异构体,可促进细胞存活。
Biochem Biophys Res Commun. 2017 Jan 22;482(4):1271-1277. doi: 10.1016/j.bbrc.2016.12.027. Epub 2016 Dec 8.
7
Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy.p53 凋亡刺激蛋白 2 的缺乏通过上调自噬减轻小鼠缺血再灌注引起的急性肾损伤。
J Cell Mol Med. 2019 Apr;23(4):2457-2467. doi: 10.1111/jcmm.14094. Epub 2019 Jan 23.
8
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.小鼠中与PTEN肿瘤抑制基因突变相关的高癌症易感性和胚胎致死性。
Curr Biol. 1998 Oct 22;8(21):1169-78. doi: 10.1016/s0960-9822(07)00488-5.
9
Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.人急性白血病中凋亡刺激蛋白 p53-2(ASPP2)的表达减弱与治疗失败相关。
PLoS One. 2013 Nov 27;8(11):e80193. doi: 10.1371/journal.pone.0080193. eCollection 2013.
10
ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.ASPP2 通过减少自噬来抑制转化生长因子-β1 在肝星状细胞中的促纤维化作用。
Dig Dis Sci. 2018 Jan;63(1):146-154. doi: 10.1007/s10620-017-4816-3. Epub 2017 Dec 2.

引用本文的文献

1
ASPPs multimerize protein phosphatase 1.ASPPs使蛋白磷酸酶1多聚化。
bioRxiv. 2025 May 19:2025.05.16.654433. doi: 10.1101/2025.05.16.654433.
2
Evaluation of apoptosis stimulating protein of TP53-1 (ASPP1/PPP1R13B) to predict therapy resistance and overall survival in acute myeloid leukemia (AML).评估 TP53-1 凋亡刺激蛋白(ASPP1/PPP1R13B)在急性髓系白血病(AML)中预测治疗耐药和总生存期的作用。
Cell Death Dis. 2024 Jan 10;15(1):25. doi: 10.1038/s41419-023-06372-0.
3
ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.ASPP2在有丝分裂期间被CDK1磷酸化,是胰腺癌细胞增殖所必需的。
Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424.
4
Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).ASPP2 的凋亡刺激蛋白 TP53-2(ASPP2)的选择性剪接导致致癌异构体的产生,从而促进软组织肉瘤(STS)的迁移和治疗耐药性。
BMC Cancer. 2022 Jul 2;22(1):725. doi: 10.1186/s12885-022-09726-7.
5
RDIVpSGP motif of ASPP2 binds to 14-3-3 and enhances ASPP2/k18/14-3-3 ternary complex formulation to promote BRAF/MEK/ERK signal inhibited cell proliferation in hepatocellular carcinoma.ASPP2的RDIVpSGP基序与14-3-3结合,增强ASPP2/k18/14-3-3三元复合物形成,以促进BRAF/MEK/ERK信号抑制肝癌细胞增殖。
Cancer Gene Ther. 2022 Nov;29(11):1616-1627. doi: 10.1038/s41417-022-00474-1. Epub 2022 May 3.
6
ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.ASPP2κ在人类结直肠癌中表达,并促进化疗耐药性和肿瘤发生。
Front Mol Biosci. 2021 Nov 5;8:727203. doi: 10.3389/fmolb.2021.727203. eCollection 2021.
7
The Effect of Surface-Modified Gold Nanorods on the Early Stage of Embryonic Development and Angiogenesis: Insight into the Molecular Pathways.表面修饰金纳米棒对胚胎早期发育和血管生成的影响:对分子途径的深入了解。
Int J Mol Sci. 2021 Oct 13;22(20):11036. doi: 10.3390/ijms222011036.
8
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.肿瘤抑制因子 ASPP2 的可变剪接导致一种应激诱导的致癌异构体,该异构体在急性白血病中普遍存在。
EBioMedicine. 2019 Apr;42:340-351. doi: 10.1016/j.ebiom.2019.03.028. Epub 2019 Apr 2.
9
ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy.ASPP2 通过减少自噬来抑制转化生长因子-β1 在肝星状细胞中的促纤维化作用。
Dig Dis Sci. 2018 Jan;63(1):146-154. doi: 10.1007/s10620-017-4816-3. Epub 2017 Dec 2.
10
ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells.ASPP2在gp120诱导的神经母细胞瘤细胞自噬和凋亡中发挥双重作用。
Front Neurosci. 2017 Mar 24;11:150. doi: 10.3389/fnins.2017.00150. eCollection 2017.

本文引用的文献

1
Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos.在缺乏凋亡刺激蛋白与前列腺素E2合成酶-1(ASPP1)的小鼠胚胎中,淋巴管组装受损。
Dev Biol. 2008 Apr 1;316(1):149-59. doi: 10.1016/j.ydbio.2008.01.023. Epub 2008 Jan 31.
2
Drosophila ASPP regulates C-terminal Src kinase activity.果蝇ASPP调节C端Src激酶活性。
Dev Cell. 2007 Dec;13(6):773-82. doi: 10.1016/j.devcel.2007.11.005.
3
p53: guardian of the genome and policeman of the oncogenes.p53:基因组守护者与癌基因警察
Cell Cycle. 2007 May 2;6(9):1006-10. doi: 10.4161/cc.6.9.4211. Epub 2007 May 28.
4
The ever expanding role for c-Myc in promoting genomic instability.c-Myc在促进基因组不稳定方面的作用不断扩大。
Cell Cycle. 2007 May 2;6(9):1024-9. doi: 10.4161/cc.6.9.4161. Epub 2007 May 19.
5
ASPP: a new family of oncogenes and tumour suppressor genes.ASPP:一个新的癌基因和肿瘤抑制基因家族。
Br J Cancer. 2007 Jan 29;96(2):196-200. doi: 10.1038/sj.bjc.6603525. Epub 2007 Jan 9.
6
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch.MYC失活后肿瘤的持续消退需要p53或血小板反应蛋白-1来逆转血管生成开关。
Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16266-71. doi: 10.1073/pnas.0608017103. Epub 2006 Oct 20.
7
ASPP2: a gene that controls life and death in vivo.ASPP2:一种在体内控制生死的基因。
Cell Cycle. 2006 Oct;5(19):2187-90. doi: 10.4161/cc.5.19.3266. Epub 2006 Oct 1.
8
Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.癌基因依赖性肿瘤抑制:利用“黑暗力量”进行癌症治疗。
Cold Spring Harb Symp Quant Biol. 2005;70:263-73. doi: 10.1101/sqb.2005.70.054.
9
ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.ASPP2是一种单倍体不足的肿瘤抑制因子,它与p53协同作用以抑制肿瘤生长。
Genes Dev. 2006 May 15;20(10):1262-7. doi: 10.1101/gad.374006.
10
Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.伴有10个或更多阳性淋巴结的乳腺癌患者的肿瘤基因表达与预后
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8623-31. doi: 10.1158/1078-0432.CCR-05-0735.

p53凋亡刺激蛋白(ASPP2)杂合小鼠易患肿瘤,且细胞损伤反应阈值降低。

Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds.

作者信息

Kampa Kerstin M, Acoba Jared D, Chen Dexi, Gay Joel, Lee Hunjoo, Beemer Kelly, Padiernos Emerson, Boonmark Nataya, Zhu Zhiyi, Fan Alice C, Bailey Alexis S, Fleming William H, Corless Christopher, Felsher Dean W, Naumovski Louie, Lopez Charles D

机构信息

Department of Medicine, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA.

出版信息

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4390-5. doi: 10.1073/pnas.0809080106. Epub 2009 Feb 26.

DOI:10.1073/pnas.0809080106
PMID:19251665
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2657427/
Abstract

The expression of ASPP2 (53BP2L), a proapoptotic member of a family of p53-binding proteins, is frequently suppressed in many human cancers. Accumulating evidence suggests that ASPP2 inhibits tumor growth; however, the mechanisms by which ASPP2 suppresses tumor formation remain to be clarified. To study this, we targeted the ASPP2 allele in a mouse by replacing exons 10-17 with a neoR gene. ASPP2(-/-) mice were not viable because of an early embryonic lethal event. Although ASPP2(+/-) mice appeared developmentally normal, they displayed an increased incidence of a variety of spontaneous tumors as they aged. Moreover, gamma-irradiated 6-week-old ASPP2(+/-) mice developed an increased incidence of high-grade T cell lymphomas of thymic origin compared with ASPP2(+/+) mice. Primary thymocytes derived from ASPP2(+/-) mice exhibited an attenuated apoptotic response to gamma-irradiation compared with ASPP2(+/+) thymocytes. Additionally, ASPP2(+/-) primary mouse embryonic fibroblasts demonstrated a defective G(0)/G(1) cell cycle checkpoint after gamma-irradiation. Our results demonstrate that ASPP2 is a haploinsufficient tumor suppressor and, importantly, open new avenues for investigation into the mechanisms by which disruption of ASPP2 pathways could play a role in tumorigenesis and response to therapy.

摘要

ASPP2(53BP2L)是一种p53结合蛋白家族的促凋亡成员,其表达在许多人类癌症中经常受到抑制。越来越多的证据表明ASPP2抑制肿瘤生长;然而,ASPP2抑制肿瘤形成的机制仍有待阐明。为了研究这一点,我们通过用neoR基因替换外显子10 - 17来靶向小鼠中的ASPP2等位基因。由于早期胚胎致死事件,ASPP2(- / -)小鼠无法存活。虽然ASPP2(+ / -)小鼠在发育上似乎正常,但随着年龄的增长,它们出现各种自发肿瘤的发生率增加。此外,与ASPP2(+ / +)小鼠相比,6周龄经γ射线照射的ASPP2(+ / -)小鼠发生胸腺起源的高级别T细胞淋巴瘤的发生率增加。与ASPP2(+ / +)胸腺细胞相比,源自ASPP2(+ / -)小鼠的原代胸腺细胞对γ射线照射表现出减弱的凋亡反应。此外,ASPP2(+ / -)原代小鼠胚胎成纤维细胞在γ射线照射后表现出缺陷的G(0)/ G(1)细胞周期检查点。我们的结果表明ASPP2是一种单倍剂量不足的肿瘤抑制因子,重要的是,为研究ASPP2途径的破坏在肿瘤发生和对治疗的反应中可能发挥作用的机制开辟了新途径。